Global pharmaceutical company AstraZeneca has announced that it is partnering with South African healthtech firm MedSol AI Solutions to help promote the use of Artificial Intelligence (AI) in the detection of breast cancer through a state-of-the-art Wi-Fi ultrasound probe that can detect the cancer in seconds.
“Breast cancer is a devastating disease, with many women in our communities only able to access late-stage diagnoses. The Melusi Breast AI project will enable us to leverage technology and innovation to improve early diagnostic detection rates and patient outcomes in local clinics, ultimately saving lives,” said Dr Kathryn Malherbe (PhD), CEO and founder of MedSol AI Solutions.
Read full article – https://techcabal.com
